Genomic profiling of thousands of candidate polymorphisms predicts risk of relapse in 778 Danish and German childhood acute lymphoblastic leukemia patients-Reference-Cited by-同舟云学术

Genomic profiling of thousands of candidate polymorphisms predicts risk of relapse in 778 Danish and German childhood acute lymphoblastic leukemia patients

Published:2014-07-03 Issue:2 Volume:29 Page:297-303
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Wesołowska-Andersen A,Borst L,Dalgaard M D,Yadav R,Rasmussen K K,Wehner P S,Rasmussen M,Ørntoft T F,Nordentoft I,Koehler R,Bartram C R,Schrappe M,Sicheritz-Ponten T,Gautier L,Marquart H,Madsen H O,Brunak S,Stanulla M,Gupta R,Schmiegelow K

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu2014205.pdf

Reference25 articles.

1. Stanulla M, Schaeffeler E, Flohr T, Cario G, Schrauder A, Zimmermann M et al. Thiopurine methyltransferase (TPMT) genotype and early treatment response to mercaptopurine in childhood acute lymphoblastic leukemia. JAMA 2005; 293: 1485–1489.

2. Davidsen ML, Dalhoff K, Schmiegelow K . Pharmacogenetics influence treatment efficacy in childhood acute lymphoblastic leukemia. J Pediatr Hematol Oncol 2008; 30: 831–849.

3. Pui CH, Mullighan CG, Evans WE, Relling MV . Pediatric acute lymphoblastic leukemia: where are we going and how do we get there? Blood 2012; 120: 1165–1174.

4. Forestier E, Schmiegelow K . The incidence peaks of the childhood acute leukemias reflect specific cytogenetic aberrations. J Pediatr Hematol Oncol 2006; 28: 486–495.

5. Davies SM, Borowitz MJ, Rosner GL, Ritz K, Devidas M, Winick N et al. Pharmacogenetics of minimal residual disease response in children with B-precursor acute lymphoblastic leukemia: a report from the Children's Oncology Group. Blood 2008; 111: 2984–2990.